Russell Clark Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$1.66M Hold
28,000
1.65% 27
2021
Q2
$1.87M Hold
28,000
1.41% 23
2021
Q1
$1.77M Hold
28,000
1.43% 24
2020
Q4
$1.74M Hold
28,000
1.63% 24
2020
Q3
$1.69M Hold
28,000
1.91% 21
2020
Q2
$1.65M Hold
28,000
2.54% 18
2020
Q1
$1.56M Buy
28,000
+9,000
+47% +$550K 2.34% 17
2019
Q4
$1.22M Buy
+19,000
New +$1.09M 0.95% 35

Other funds holding BMY

Russell Clark Investment Management's BMY Position: Q3 2021 in Review

Russell Clark Investment Management held its Bristol-Myers Squibb (BMY) position steady in Q3 2021 at 28,000 shares worth $1.66M. The position accounts for 1.65% of the portfolio, ranked #27.

Russell Clark Investment Management first reported a position in BMY in Q4 2019 and has held it in 8 quarters since. The position peaked at $1.87M in Q2 2021. 2,293 funds tracked by Wall St. Rank hold BMY as of Q3 2021.

  • Russell Clark Investment Management held 28,000 shares of Bristol-Myers Squibb worth $1.66M as of Q3 2021.
  • Russell Clark Investment Management left its Bristol-Myers Squibb share count unchanged in Q3 2021.
  • Bristol-Myers Squibb made up 1.65% of Russell Clark Investment Management's portfolio in Q3 2021, its #27 holding.
  • Russell Clark Investment Management first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 8 quarters since.
  • Russell Clark Investment Management's Bristol-Myers Squibb position peaked at $1.87M in Q2 2021.
  • 2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.

Based on Russell Clark Investment Management's 13F filing for Q3 2021, filed 3 Nov 2021.